ProfileGDS4718 / 1564721_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 20% 19% 19% 24% 24% 23% 20% 22% 27% 29% 20% 21% 19% 16% 22% 20% 23% 16% 17% 18% 25% 26% 24% 26% 20% 24% 21% 18% 28% 16% 18% 16% 22% 24% 21% 19% 21% 28% 24% 17% 26% 15% 21% 17% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.170220
GSM549102patient 115, normal, homogenized [OPG study]4.1404319
GSM549104patient 119, normal, homogenized [OPG study]4.0842419
GSM549108patient 138, normal, homogenized [OPG study]4.3387424
GSM549119patient 077, normal, homogenized [OPG study]4.3055724
GSM549133patient 032, cancer, homogenized [OPG study]4.1933223
GSM549139patient 042, cancer, homogenized [OPG study]4.1259920
GSM549099patient 107, normal, homogenized [OPG study]4.2359522
GSM549109patient 139, normal, homogenized [OPG study]4.431527
GSM549110patient 046, normal, homogenized [OPG study]4.4954429
GSM549114patient 063, normal, homogenized [OPG study]4.1205220
GSM549122patient 082, normal, homogenized [OPG study]4.1844721
GSM549134patient 033, cancer, homogenized [OPG study]4.0845819
GSM549136patient 036, cancer, homogenized [OPG study]3.9518316
GSM549140patient 044, cancer, homogenized [OPG study]4.1816822
GSM549111patient 047, normal, homogenized [OPG study]4.1143520
GSM549113patient 057, normal, homogenized [OPG study]4.2059923
GSM549132patient 031, cancer, homogenized [OPG study]3.9763516
GSM549137patient 038, cancer, homogenized [OPG study]4.0068717
GSM549142patient 047, cancer, homogenized [OPG study]4.1335718
GSM549100patient 110, normal, homogenized [OPG study]4.3661825
GSM549107patient 135, normal, homogenized [OPG study]4.3292526
GSM549115patient 068, normal, homogenized [OPG study]4.2425824
GSM549116patient 072, normal, homogenized [OPG study]4.3692526
GSM549120patient 078, normal, homogenized [OPG study]4.1547920
GSM549131patient 030, cancer, homogenized [OPG study]4.2352624
GSM549118patient 074, normal, homogenized [OPG study]4.2029721
GSM549129patient 027, cancer, homogenized [OPG study]4.0934518
GSM549123patient 088, normal, homogenized [OPG study]4.4382628
GSM549124patient 006, cancer, homogenized [OPG study]4.0472416
GSM549126patient 015, cancer, homogenized [OPG study]4.063918
GSM549128patient 025, cancer, homogenized [OPG study]3.9815316
GSM549103patient 117, normal, homogenized [OPG study]4.2803722
GSM549117patient 073, normal, homogenized [OPG study]4.2877124
GSM549138patient 041, cancer, homogenized [OPG study]4.1710221
GSM549141patient 045, cancer, homogenized [OPG study]4.0342519
GSM549130patient 028, cancer, homogenized [OPG study]4.2149221
GSM549101patient 111, normal, homogenized [OPG study]4.4666628
GSM549105patient 128, normal, homogenized [OPG study]4.3341124
GSM549106patient 134, normal, homogenized [OPG study]3.992817
GSM549112patient 048, normal, homogenized [OPG study]4.3758926
GSM549125patient 011, cancer, homogenized [OPG study]3.9822615
GSM549127patient 024, cancer, homogenized [OPG study]4.1496721
GSM549135patient 035, cancer, homogenized [OPG study]3.9941917